ANXA6 and head and neck squamous cell carcinoma: Elevated TRPV2 expression correlates with poor prognosis in HNSCC patients, while ANXA6 facilitates autophagy and lymphatic metastasis in HNSCC by modulating TRPV2 expression through mTOR phosphorylation inhibition (51).